Portfolio Update

RNS Number : 9184X
Intl. Biotechnology Trust PLC
15 August 2018
 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

 

Portfolio Update

 

The Board of International Biotechnology Trust plc (the Company) notes the following unquoted portfolio event.

 

The Company has received quarterly investor reporting in relation to its investment in the unlisted venture capital fund, SV Fund VI.

 

SV Fund VI's latest quarterly investor report values the Company's investment at $25.0m (£19.6m), an uplift of $3.4m (£2.7m) on the valuation of $21.6m (£16.9m) which was included in the Company's Net Asset Value (NAV) calculation for 13 August 2018.

 

In line with the Company's accounting policy, valuation movements following receipt of quarterly investor reports are reflected in the next reported NAV.  Therefore, the increase in NAV to be reported today, as at 14 August 2018, will be £2.7m or 7.2 pence per share.

 

Enquiries:

 

Kate Bingham/Carl Harald Janson

Telephone: 020 7421 7070

SV Health Managers LLP

Investment Manager

 

15 August 2018

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PFUBXGDIGGBBGIU
Investor Meets Company
UK 100